-
2
-
-
0032400929
-
Symptom relief and side effects of postmenopausal hormones: Results from the Postmenopausal Estrogen/Progestin Interventions Trial
-
Greendale GA, Reboussin BA, Hogan P, Barnabei VM, Shumaker S, Johnson S, et al. Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial. Obstet Gynecol 1998; 92: 982-988.
-
(1998)
Obstet Gynecol
, vol.92
, pp. 982-988
-
-
Greendale, G.A.1
Reboussin, B.A.2
Hogan, P.3
Barnabei, V.M.4
Shumaker, S.5
Johnson, S.6
-
3
-
-
0033346803
-
Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women
-
Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab 1999; 84: 4025-4030.
-
(1999)
J Clin Endocrinol Metab
, vol.84
, pp. 4025-4030
-
-
Dennerstein, L.1
Dudley, E.C.2
Hopper, J.L.3
Guthrie, J.R.4
Burger, H.G.5
-
4
-
-
0027296111
-
A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections
-
Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993; 329: 753-756.
-
(1993)
N Engl J Med
, vol.329
, pp. 753-756
-
-
Raz, R.1
Stamm, W.E.2
-
5
-
-
0029907556
-
Effects of hormone therapy on bone mineral density: Results from the postmenopausal estrogen/progestin interventions (PEPI) trial
-
The Writing Group for the PEPI Trial
-
The Writing Group for the PEPI Trial. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. JAMA 1996; 276: 1389-1396.
-
(1996)
JAMA
, vol.276
, pp. 1389-1396
-
-
-
6
-
-
0035854023
-
Postmenopausal hormone therapy for prevention of fractures: How good is the evidence?
-
Grady D, Cumming SR. Postmenopausal hormone therapy for prevention of fractures: how good is the evidence? JAMA 2001; 285: 2909-2910.
-
(2001)
JAMA
, vol.285
, pp. 2909-2910
-
-
Grady, D.1
Cumming, S.R.2
-
7
-
-
0031866317
-
Hormone replacement therapy, heart disease, and other considerations
-
Barrett-Connor E, Grady, D. Hormone replacement therapy, heart disease, and other considerations. Ann Rev Pub Health 1998; 19: 55-72.
-
(1998)
Ann Rev Pub Health
, vol.19
, pp. 55-72
-
-
Barrett-Connor, E.1
Grady, D.2
-
8
-
-
0037309386
-
Hormone replacement therapy in postmenopausal women with Alzheimer's disease: A randomized, prospective study
-
Yoon BK, Kim DK, Kang Y, Kim JW, Shin MH, Na DL. Hormone replacement therapy in postmenopausal women with Alzheimer's disease: a randomized, prospective study. Fertil Steril 2003; 79: 274-280.
-
(2003)
Fertil Steril
, vol.79
, pp. 274-280
-
-
Yoon, B.K.1
Kim, D.K.2
Kang, Y.3
Kim, J.W.4
Shin, M.H.5
Na, D.L.6
-
9
-
-
0035408189
-
Vascular effects of estrogens: Arterial protection versus venous thrombotic risk
-
Bracamonte MP, Miller VM. Vascular effects of estrogens: arterial protection versus venous thrombotic risk. Trends Endocrinol Metab 2001; 12: 204-209.
-
(2001)
Trends Endocrinol Metab
, vol.12
, pp. 204-209
-
-
Bracamonte, M.P.1
Miller, V.M.2
-
10
-
-
0031830274
-
Hormone replacement therapy and prevention of postmenopausal cardiovascular diseases
-
Grand A. Hormone replacement therapy and prevention of postmenopausal cardiovascular diseases. Ann Cardiol Angeiol (Paris). 1998; 47: 481-487.
-
(1998)
Ann Cardiol Angeiol (Paris)
, vol.47
, pp. 481-487
-
-
Grand, A.1
-
11
-
-
0032420244
-
Hormone replacement therapy: Cardiovascular benefits for aging women
-
Sites CK. Hormone replacement therapy: cardiovascular benefits for aging women. Coron Artery Dis 1998; 9: 789-793.
-
(1998)
Coron Artery Dis
, vol.9
, pp. 789-793
-
-
Sites, C.K.1
-
12
-
-
0028293018
-
The effects of transdermal estradiol and oral conjugated estrogens on haemostasis variables
-
Kroon UB, Silfverstolpe G, Tengborn L. The effects of transdermal estradiol and oral conjugated estrogens on haemostasis variables. Thromb Haemost 1994; 71: 420-423.
-
(1994)
Thromb Haemost
, vol.71
, pp. 420-423
-
-
Kroon, U.B.1
Silfverstolpe, G.2
Tengborn, L.3
-
13
-
-
0011301940
-
Pathogenesis Of Thrombosis
-
Williams JW, editor. 5th ed. New York: Mcgraw Hill
-
Loscalzo J. Pathogenesis Of Thrombosis. In: Williams JW, editor. Hematology. 5th ed. New York: Mcgraw Hill; 1995. p. 1525-1531.
-
(1995)
Hematology
, pp. 1525-1531
-
-
Loscalzo, J.1
-
14
-
-
0032903040
-
Oral contraceptives and hormonal replacement therapy cause an imbalance in coagulation and fibrinolysis which may explain the increased risk of venous thromboembolism
-
Levi M, Middeldorp S, Buller HR. Oral contraceptives and hormonal replacement therapy cause an imbalance in coagulation and fibrinolysis which may explain the increased risk of venous thromboembolism. Cardiovasc Res 1999; 41: 21-24.
-
(1999)
Cardiovasc Res
, vol.41
, pp. 21-24
-
-
Levi, M.1
Middeldorp, S.2
Buller, H.R.3
-
15
-
-
0034101946
-
Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis
-
Teede HJ, McGrath BP, Smolich JJ, Malan E, Kotsopoulos D, Liang YL, et al. Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis. Arterioscler Thromb Vasc Biol 2000; 20: 1404-1409.
-
(2000)
Arterioscler Thromb Vasc Biol
, vol.20
, pp. 1404-1409
-
-
Teede, H.J.1
McGrath, B.P.2
Smolich, J.J.3
Malan, E.4
Kotsopoulos, D.5
Liang, Y.L.6
-
16
-
-
0034595197
-
Postmenopausal hormone therapy increases risk for venous thromboembolic disease
-
The Heart and Estrogen/progestin Replacement Study
-
Grady D, Wenger NK, Herrington D, Khan S, Furberg C, Hunninghake D, et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study. Ann Intern Med 2000; 132: 689-696.
-
(2000)
Ann Intern Med
, vol.132
, pp. 689-696
-
-
Grady, D.1
Wenger, N.K.2
Herrington, D.3
Khan, S.4
Furberg, C.5
Hunninghake, D.6
-
17
-
-
0037125379
-
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial
-
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-333.
-
(2002)
JAMA
, vol.288
, pp. 321-333
-
-
Rossouw, J.E.1
Anderson, G.L.2
Prentice, R.L.3
LaCroix, A.Z.4
Kooperberg, C.5
Stefanick, M.L.6
-
18
-
-
3142683004
-
Hormone replacement therapy in postmenopausal women
-
Staren ED, Omer S. Hormone replacement therapy in postmenopausal women. Am J Surg 2004; 188: 136-149.
-
(2004)
Am J Surg
, vol.188
, pp. 136-149
-
-
Staren, E.D.1
Omer, S.2
-
19
-
-
0036731679
-
The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice
-
Lemay A. The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice. J Obstet Gynaecol Can 2002; 24: 711-715.
-
(2002)
J Obstet Gynaecol Can
, vol.24
, pp. 711-715
-
-
Lemay, A.1
-
20
-
-
0027153282
-
Fibrinogen as a Cardiovascular Risk Factor: A Meta-analysis and Review of the Literature
-
Ernst E, Resch KI. Fibrinogen as a Cardiovascular Risk Factor: A Meta-analysis and Review of the Literature. Ann Intern Med 1993; 15: 956-963.
-
(1993)
Ann Intern Med
, vol.15
, pp. 956-963
-
-
Ernst, E.1
Resch, K.I.2
-
21
-
-
0031443428
-
Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial
-
Scarabin PY, Alhenc-Gelas M, Plu-Bureau G, Taisne P, Agher R, Aiach M. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial. Arterioscler Thromb Vasc Biol 1997; 17: 3071-3078.
-
(1997)
Arterioscler Thromb Vasc Biol
, vol.17
, pp. 3071-3078
-
-
Scarabin, P.Y.1
Alhenc-Gelas, M.2
Plu-Bureau, G.3
Taisne, P.4
Agher, R.5
Aiach, M.6
-
22
-
-
0033175413
-
The influence of hormone replacement therapy containing transdermal 17-Beta estradiol and oral medroxyprogesterone acetate on coagulation and fibrinolysis
-
Stachowiak G, Owczarek D, Polac I, Pertynski T, Jedrzejczyk S. The influence of hormone replacement therapy containing transdermal 17-Beta estradiol and oral medroxyprogesterone acetate on coagulation and fibrinolysis. Ginekol Pol 1999; 70: 527-533.
-
(1999)
Ginekol Pol
, vol.70
, pp. 527-533
-
-
Stachowiak, G.1
Owczarek, D.2
Polac, I.3
Pertynski, T.4
Jedrzejczyk, S.5
-
23
-
-
0037014410
-
Effects of hormone replacement therapy and estrogen receptor modulators on markers of inflammation and coagulation
-
Cushman M. Effects of hormone replacement therapy and estrogen receptor modulators on markers of inflammation and coagulation. Am J Cardiol 2002; 90: 7F-10F.
-
(2002)
Am J Cardiol
, vol.90
-
-
Cushman, M.1
-
24
-
-
0034950083
-
Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism
-
Lobo RA, Bush T, Carr BR, Pickar JH. Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism. Fertil Steril 2001; 76: 13-24.
-
(2001)
Fertil Steril
, vol.76
, pp. 13-24
-
-
Lobo, R.A.1
Bush, T.2
Carr, B.R.3
Pickar, J.H.4
-
25
-
-
0032837217
-
Changes in coagulation factors and fibrinolytic components of postmenopausal women receiving continuous hormone replacement therapy
-
Nozaki M, Ogata R, Koera K, Hashimoto K, Nakano H. Changes in coagulation factors and fibrinolytic components of postmenopausal women receiving continuous hormone replacement therapy. Climacteric 1999; 2: 124-130.
-
(1999)
Climacteric
, vol.2
, pp. 124-130
-
-
Nozaki, M.1
Ogata, R.2
Koera, K.3
Hashimoto, K.4
Nakano, H.5
-
26
-
-
0034191203
-
Effect of hormone replacement therapy on coagulation function in postmenopausal women
-
Ye Y, Gao P, Guo X. Effect of hormone replacement therapy on coagulation function in postmenopausal women. Zhonghua Fu Chan Ke Za Zhi 2000; 35: 285-287.
-
(2000)
Zhonghua Fu Chan Ke Za Zhi
, vol.35
, pp. 285-287
-
-
Ye, Y.1
Gao, P.2
Guo, X.3
-
27
-
-
0033128668
-
Modification of the hemostatic balance during estrogen treatments: Menopause and its treatment
-
Conard J. Modification of the hemostatic balance during estrogen treatments: menopause and its treatment. Therapie 1999; 54: 363-370.
-
(1999)
Therapie
, vol.54
, pp. 363-370
-
-
Conard, J.1
-
28
-
-
0037172942
-
Combined oral estradiol valerate-norethisterone treatment over 3 years in postmenopausal women: Effect on lipids, coagulation factors, haematology and biochemistry
-
Perry W, Wiseman RA. Combined oral estradiol valerate-norethisterone treatment over 3 years in postmenopausal women: effect on lipids, coagulation factors, haematology and biochemistry. Maturitas 2002; 42: 157-164.
-
(2002)
Maturitas
, vol.42
, pp. 157-164
-
-
Perry, W.1
Wiseman, R.A.2
-
29
-
-
0036202887
-
Interaction of hemostatic genetics with hormone therapy: New insights to explain arterial thrombosis in postmenopausal women
-
Braunstein JB, Kershner DW, Bray P, Gerstenblith G, Schulman SP, Post WS, et al. Interaction of hemostatic genetics with hormone therapy: new insights to explain arterial thrombosis in postmenopausal women. Chest 2002; 121: 906-920.
-
(2002)
Chest
, vol.121
, pp. 906-920
-
-
Braunstein, J.B.1
Kershner, D.W.2
Bray, P.3
Gerstenblith, G.4
Schulman, S.P.5
Post, W.S.6
-
30
-
-
0034928806
-
Post-menopausal hormone therapy and concentrations of protein C and antithrombin in elderly women
-
Cushman M, Psaty BM, Meilahn EN, Dobs AS, Kuller LH. Post-menopausal hormone therapy and concentrations of protein C and antithrombin in elderly women. Br J Haematol 2001; 114: 162-168.
-
(2001)
Br J Haematol
, vol.114
, pp. 162-168
-
-
Cushman, M.1
Psaty, B.M.2
Meilahn, E.N.3
Dobs, A.S.4
Kuller, L.H.5
-
31
-
-
0035022569
-
The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism - results from a randomized, double-blind, clinical trial
-
Hoibraaten E, Qvigstad E, Andersen TO, Mowinckel MC, Sandset PM. The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial. Thromb Haemost 2001; 85: 775-781.
-
(2001)
Thromb Haemost
, vol.85
, pp. 775-781
-
-
Hoibraaten, E.1
Qvigstad, E.2
Andersen, T.O.3
Mowinckel, M.C.4
Sandset, P.M.5
-
32
-
-
0036074792
-
Hormone replacement therapy and the factor V Leiden mutation
-
Bauer KA. Hormone replacement therapy and the factor V Leiden mutation. Arterioscler Thromb Vasc Biol 2002; 22: 879-880.
-
(2002)
Arterioscler Thromb Vasc Biol
, vol.22
, pp. 879-880
-
-
Bauer, K.A.1
|